昂利康(002940.SZ)：多索茶碱片通过仿制药一致性评价

Core Viewpoint - The company, Anglikang (002940.SZ), has received approval from the National Medical Products Administration for its drug, Doxofylline Tablets, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approved Doxofylline Tablets are available in dosages of 0.2g and 0.4g [1] - Doxofylline Tablets are indicated for bronchial asthma, asthmatic chronic bronchitis, and other respiratory difficulties caused by bronchospasm [1]